1269292-02-5

Basic information

• Product Name: 3-bromo-2-methyl-5-nitrobenzoic acid
• Synonyms: 3-bromo-2-methyl-5-nitrobenzoic acid
• CAS NO: 1269292-02-5
• Molecular Weight: 260.044
• Mol File: 1269292-02-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 395.7±42.0 °C(Predicted)
• Density: 1.777±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-bromo-2-methyl-5-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-2-methyl-5-nitrobenzoic acid(1269292-02-5)
• EPA Substance Registry System: 3-bromo-2-methyl-5-nitrobenzoic acid(1269292-02-5)

Safety Data

• Hazardous Substances Data: 1269292-02-5(Hazardous Substances Data)

Upstream product

• 1975-52-6 5-nitro-o-toluic acid 

Downstream Products

• 1422958-90-4 1-(5-(N-(phenoxyacetyl)amino)phthalimid-3-yl)-1,2-dideoxy-β-D-ribofuranose 
• 1422958-95-9 1-(5-(N-(phenoxyacetyl)amino)-N-(4,4'-dimethoxytrityl)phthalimid-3-yl)-5-O-(4,4'-dimethoxytrityl)-1,2-dideoxy-β-D-ribofuranose 
• 1422958-97-1 1-(5-(N-(phenoxyacetyl)amino)-N-(4,4'-dimethoxytrityl)phthalimid-3-yl)-3-O-[(2-cyanoethoxy)diisopropylaminophosphanyl]-5-O-(4,4'-dimethoxytrityl)-1,2-dideoxy-β-D-ribofuranose 
• 1422958-91-5 C₄₂H₃₈N₂O₉ 
• 1422958-93-7 C₅₁H₅₅N₄O₁₀P 
• 885519-05-1 methyl 3-bromo-2-methyl-5-nitrobenzoate 

Relevant articles and documents

Synthesis of 4-aminophthalimide and 2,4-diaminopyrimidine C-nucleosides as isosteric fluorescent DNA base substitutes

The 4-aminophthalimide C-nucleoside 1 was designed as an isosteric DNA base surrogate, and a synthetic route to nucleoside 1 together with the 2,4-diaminopyrimidine-C-nucleoside 2 as a potential counterbase was worked out. The key steps in both synthetic

BENZOFURAN DERIVATIVE, PREPARATION METHOD THEREOF AND USE THEREOF IN MEDICINE

The present invention relates to a benzofuran derivative, a preparation method thereof and a use thereof in medicine. In particular, the present invention relates to the benzofuran derivative as shown by general formula (I), the preparation method thereof, a pharmaceutical composition containing the derivative, and uses thereof as an EZH2 inhibitor and in the prevention and/or treatment of diseases such as tumours and cancers, etc., and in particular uses thereof in the prevention and/or treatment of non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma and synovial sarcoma, wherein the definitions of the substituents in the general formula (I) are the same as those defined in the description.